Medical Device Sales Rep Salary by Specialty (2026)

I was on a call with a hiring manager at a mid-size orthopedic company in Memphis last fall. She wanted to bring on two contractors for a territory that had been sitting empty for four months. Before we got into the candidate pool she asked: "What are ortho reps making these days? I haven't benchmarked in two years."

I gave her a range. She came back with: "That's higher than I expected."

It was. But ortho is not the same market as cardiovascular. It is not the same market as infusion. And it is definitely not the same market as surgical robotics, which has developed its own compensation grammar entirely in the past three years. If you are hiring across specialties or trying to set up competitive contractor rates, using a single "medical device rep salary" benchmark is roughly as useful as averaging the price of a BMW and a used Civic and calling it the price of a car.

The ranges below come from about 35 placements and contractor engagements over the last 18 months. This is useful directional data, not a perfect market census. I am focusing on experienced reps (three-plus years in specialty) in mid-size metro markets. Coastal markets usually run about 8-14% higher, and rural markets can look cheaper on base but sometimes close the gap on total comp when case volume is strong.

Separately, for medical device roles specifically, MDliaison offers both contractor arrangements and commission-only engagements. I will come back to what that distinction means in practice at the end.

Orthopedic (Joints and Extremities)

Ortho remains one of the most competitive recruiting environments in device. The case-based model means top reps can dramatically outperform their base, but it also means variance is high. A rep covering a territory with three active surgeons in a busy ASC is in a very different income situation than one covering a rural hospital system with two OR days a week.

Base compensation for experienced ortho reps in mid-size markets runs $68K-$82K. Total comp for a solid performer in a healthy territory lands $118K-$171K — that's across about nine placements, which isn't a huge sample, so treat it as a directional range rather than a hard benchmark. Outliers above $200K show up in dense urban markets with high-volume surgeons but those are genuinely unusual and you shouldn't be structuring your offer around them.

The thing that distinguishes ortho hiring right now is the expectation around OR presence. Companies want reps who have existing relationships with surgical techs and OR nurses, not just surgeons. That relationship capital is priced in, and it should be.

Spine

Spine pays more than ortho at nearly every level, and has for the past several years. The complexity of the sale, the OR time commitment, and the liability that comes with being in the room during a spine procedure all push compensation up. Base range is $74K-$91K; total comp for a performer is $134K-$197K.

Worth noting: spine is also the specialty where the variance between contractor and W2 compensation tends to be widest. Some companies pay contractors in spine noticeably less than they'd pay a W2 equivalent, operating on the assumption that the flexibility premium compensates for the gap. Across roughly a dozen spine engagements, that assumption is wrong. The reps who know their value in spine know exactly what W2 roles pay.

Cardiovascular

Cardiovascular is a more stable market from a compensation standpoint than ortho or spine. The quota structures tend to be quarterly, more predictable, and tied to account volume rather than individual case performance. Base range: $71K-$88K; total comp: $119K-$162K.

The major shift in cardiovascular right now is the increasing product complexity around structural heart and electrophysiology. Reps covering EP or structural heart command a noticeable premium over those covering more commodity cardiovascular lines. If you are hiring for EP or structural heart and benchmarking against general cardiovascular, you are going to lose candidates.

Surgical Robotics

This is the outlier category. The combination of high-stakes sales cycles, deep clinical training requirements, and the capital equipment component has pushed surgical robotics compensation well above most other device specialties. Base range is $83K-$107K; total comp for a strong performer lands at $161K-$228K, based on about seven engagements.

The utilization component is what drives the upper end of that range. Robotics reps are not just selling placements; they are responsible for keeping utilization numbers up on systems that cost hospitals millions of dollars. That ongoing revenue accountability is priced differently than a one-time case commission.

If you are trying to hire an experienced robotics rep with an existing surgeon network as a contractor, expect to pay at or above the top of that base range. These candidates have plenty of options.

Neuromodulation, Infusion, and Wound Care

I am grouping these three not because they are similar markets but because they tend to be overlooked in salary conversations that focus on the higher-profile specialties.

Neuromodulation (spinal cord stimulation, deep brain stimulation, peripheral nerve) runs $69K-$84K base, $112K-$153K total comp. Infusion and biologic delivery is slightly lower: $61K-$76K base, $94K-$133K total comp. Wound care is the lowest of the group at $54K-$68K base, though account-based commission structures can push total comp meaningfully higher in large IDN territories.

The underestimated thing about wound care and infusion hiring is tenure. These reps tend to stay in accounts for a long time and develop deep clinical relationships that are genuinely difficult to replace. The salary market does not fully price that in.

A Note on Commission-Only, Which Is Different

Device is the one category where two engagement structures are genuinely on the table. The contractor marketplace applies across categories, but commission-only is device-specific. Teams sometimes assume those options exist everywhere once they hear about them in device; they do not.

For device, commission-only works well in categories with strong reorder dynamics and short sales cycles. It is harder to execute in spine or robotics, where a rep needs months of OR time before revenue appears. Experienced reps in those specialties know what W2 roles pay and are not going to accept a commission-only structure that does not reflect that. Most device companies I work with start with a contractor arrangement to validate the territory before deciding whether commission-only makes sense at all. Related: The Cost of an Empty Medical Device Territory.

She asked one more practical question before we hung up: should she anchor contractor rates to base or to total comp? Real answer: neither cleanly. It usually lands in between and moves with territory maturity, surgeon access, and rep tenure. Use these ranges as a starting frame, then sanity-check live market conditions before you post a number, especially in spine and robotics.